123 related articles for article (PubMed ID: 8687158)
21. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.
Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR
J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity in proliferation markers in colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
[TBL] [Abstract][Full Text] [Related]
24. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
25. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
26. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients.
Gumus E; Erdamar S; Demirel G; Horasanli K; Kendirci M; Miroglu C
Int J Urol; 2004 Dec; 11(12):1070-7. PubMed ID: 15663677
[TBL] [Abstract][Full Text] [Related]
27. Colon cancer: p53 expression and DNA ploidy. Their relation to proximal or distal tumor site.
García-Hirschfeld García J; Blanes Berenguel A; Vicioso Recio L; Márquez Moreno A; Rubio Garrido J; Matilla Vicente A
Rev Esp Enferm Dig; 1999 Jul; 91(7):481-8. PubMed ID: 10477366
[TBL] [Abstract][Full Text] [Related]
28. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.
Lenz HJ; Danenberg KD; Leichman CG; Florentine B; Johnston PG; Groshen S; Zhou L; Xiong YP; Danenberg PV; Leichman LP
Clin Cancer Res; 1998 May; 4(5):1227-34. PubMed ID: 9607581
[TBL] [Abstract][Full Text] [Related]
29. P53 expression in synchronous colorectal cancer.
Yalcinkaya U; Ozturk E; Ozgur T; Yerci O; Yilmazlar T
Saudi Med J; 2008 Jun; 29(6):826-31. PubMed ID: 18521459
[TBL] [Abstract][Full Text] [Related]
30. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
33. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of nuclear DNA of 106 colorectal tumors, determined with microspectrocytophotometry].
Díaz Aguirregoitia FJ; García-Alonso Montoya I; Iturburu Belmonte I; Portugal Porras V; Alonso Varona A; Echevarría García-Sanfrechoso A; Méndez Martín J
Rev Esp Enferm Dig; 1993 Jun; 83(6):421-8. PubMed ID: 8338705
[TBL] [Abstract][Full Text] [Related]
35. Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Terada T; Shimizu K; Izumi R; Nakanuma Y
Mod Pathol; 1994 Feb; 7(2):249-52. PubMed ID: 8008749
[TBL] [Abstract][Full Text] [Related]
36. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
38. Bcl-w expression in colorectal adenocarcinoma.
Wilson JW; Nostro MC; Balzi M; Faraoni P; Cianchi F; Becciolini A; Potten CS
Br J Cancer; 2000 Jan; 82(1):178-85. PubMed ID: 10638987
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
Gershenson DM; Deavers M; Diaz S; Tortolero-Luna G; Miller BE; Bast RC; Mills GB; Silva EG
Clin Cancer Res; 1999 Dec; 5(12):4053-8. PubMed ID: 10632339
[TBL] [Abstract][Full Text] [Related]
40. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
